Nisoldipino [Inn-Spanish] en es it fr

Nisoldipino [Inn-Spanish] Brand names, Nisoldipino [Inn-Spanish] Analogs

Nisoldipino [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Nisoldipino [Inn-Spanish] Chemical_Formula


Nisoldipino [Inn-Spanish] RX_link

Nisoldipino [Inn-Spanish] fda sheet

Nisoldipino [Inn-Spanish] msds (material safety sheet)

Nisoldipino [Inn-Spanish] Synthesis Reference

No information avaliable

Nisoldipino [Inn-Spanish] Molecular Weight

388.414 g/mol

Nisoldipino [Inn-Spanish] Melting Point

No information avaliable

Nisoldipino [Inn-Spanish] H2O Solubility

No information avaliable

Nisoldipino [Inn-Spanish] State


Nisoldipino [Inn-Spanish] LogP


Nisoldipino [Inn-Spanish] Dosage Forms

No information avaliable

Nisoldipino [Inn-Spanish] Indication


Nisoldipino [Inn-Spanish] Pharmacology

Nisoldipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nisoldipine is similar to other peripheral vasodilators. Nisoldipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

Nisoldipino [Inn-Spanish] Absorption

No information avaliable

Nisoldipino [Inn-Spanish] side effects and Toxicity

No information avaliable

Nisoldipino [Inn-Spanish] Patient Information

Nisoldipino [Inn-Spanish] Organisms Affected

Humans and other mammals